|1.||Armsby, C C: 1 article (06/2014)|
|2.||Even, K M: 1 article (06/2014)|
|3.||Bateman, S T: 1 article (06/2014)|
|4.||Le Foll, Bernard: 1 article (01/2014)|
|5.||Ali, Robert: 1 article (01/2014)|
|6.||Gowing, Linda: 1 article (01/2014)|
|7.||Marshall, Kushani: 1 article (01/2014)|
|8.||Liang, Wei: 1 article (11/2013)|
|9.||Yang, Shichang: 1 article (11/2013)|
|10.||Zhang, Yingli: 1 article (11/2013)|
02/01/2003 - "Newer medications such as atypical antidepressants and anticonvulsants may be overtaking older antidepressants, but they should not be overlooked as important options for the management of pain."
01/01/2013 - "These new drugs that are effective for chronic pain belong to the tetracyclic antidepressants (TeCAs) group (amoxapine, maprotiline), the serotonin and noradrenaline reuptake inhibitors (SNRIs) group (duloxetine, venlafaxine, milnacipran) and the atypical antidepressants group (bupropion, trazodone, mirtazapine, nefazodone). "
|2.||Post-Traumatic Stress Disorders (PTSD)
01/01/2003 - "This review examines some of the basic neurobiological abnormalities observed in PTSD and summarizes open and controlled drug trials for major classes of medications, including SSRIs, other antidepressants, atypical neuroleptics, noradrenergic modulators and anticonvulsants, while critically evaluating the extent of effectiveness of these agents and reviewing unmet gaps in therapeutic need."
|3.||Marijuana Abuse (Cannabis Abuse)
01/01/2014 - "The quantitative analyses that were possible, combined with general findings of the studies reviewed, indicate that SSRI antidepressants, mixed action antidepressants, atypical antidepressants (bupropion), anxiolytics (buspirone) and norepinephrine reuptake inhibitors (atomoxetine) are probably of little value in the treatment of cannabis dependence. "
|4.||Bipolar Disorder (Mania)
11/01/2009 - "Other therapies used for bipolar disorder, including several mood stabilizers, antidepressants, atypical antipsychotics and benzodiazepines, have been shown to reduce anxiety symptoms, but specific data for their effects in patients with anxiety symptoms co-morbid with bipolar disorder are not available. "
11/05/2013 - "The keywords "bipolar disorder, bipolar I disorder, bipolar II disorder, bipolar mania, bipolar depression, cyclothymia, mixed mania and depression, rapid cycling and bipolar disorder", AND "antidepressant agent, antidepressive agents second- generation, antidepressive agents tricyclic, monoamine oxidase inhibitor, noradrenaline uptake inhibitor, serotonin uptake inhibitor, and tricyclic antidepressant agent" were used. "
|5.||Overactive Urinary Bladder (Overactive Bladder)
08/01/2010 - "Medications assessed as independent variables were conventional antipsychotics, atypical antipsychotics, selective serotonin-reuptake inhibitors, tricyclic antidepressants, atypical antidepressants, monoamine oxidase inhibitors, lithium, anticonvulsants, benzodiazepines, nonbenzodiazepine sleep aids, Alzheimer's disease medications, antihistamines, antiarrhythmics, antihypertensives, benign prostatic hyperplasia medications, oral hypoglycemic agents, histamine H(2)-receptor blockers, laxatives and stool softeners, muscle relaxants, nonsteroidal antiinflammatory drugs, opioids, Parkinson's disease medications, and overactive bladder medications. "
|2.||Antidepressive Agents (Antidepressants)
|4.||Serotonin (5 Hydroxytryptamine)